| Acetylated histone variant H2A. Z is involved in the activation of neo-enhancers in prostate cancer F Valdés-Mora, CM Gould, Y Colino-Sanguino, W Qu, JZ Song, KM Taylor, ... Nature Communications 8 (1), 1346, 2017 | 83 | 2017 |
| DNA hypermethylation encroachment at CpG island borders in cancer is predisposed by H3K4 monomethylation patterns K Skvortsova, E Masle-Farquhar, PL Luu, JZ Song, W Qu, E Zotenko, ... Cancer cell 35 (2), 297-314. e8, 2019 | 77 | 2019 |
| Single-cell transcriptomics reveals involution mimicry during the specification of the basal breast cancer subtype F Valdes-Mora, R Salomon, BS Gloss, AMK Law, J Venhuizen, L Castillo, ... Cell Reports 35 (2), 2021 | 50 | 2021 |
| The H2A. Z-nucleosome code in mammals: emerging functions Y Colino-Sanguino, SJ Clark, F Valdes-Mora Trends in Genetics 38 (3), 273-289, 2022 | 47 | 2022 |
| Cyclosporin promotes neurorestoration and cell replacement therapy in pre-clinical models of Parkinson’s disease A Tamburrino, MJ Churchill, OW Wan, Y Colino-Sanguino, R Ippolito, ... Acta neuropathologica communications 3, 1-14, 2015 | 40 | 2015 |
| Cell lineage tracing identifies hormone-regulated and Wnt-responsive vaginal epithelial stem cells A Ali, SM Syed, MFB Jamaluddin, Y Colino-Sanguino, D Gallego-Ortega, ... Cell reports 30 (5), 1463-1477. e7, 2020 | 37 | 2020 |
| A read/write mechanism connects p300 bromodomain function to H2A. Z acetylation Y Colino-Sanguino, EM Cornett, D Moulder, GC Smith, J Hrit, ... Iscience 21, 773-788, 2019 | 22 | 2019 |
| ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma ER Jackson, RJ Duchatel, DE Staudt, ML Persson, A Mannan, S Yadavilli, ... Cancer research 83 (14), 2421-2437, 2023 | 20 | 2023 |
| Clinical relevance of the transcriptional signature regulated by CDC42 in colorectal cancer F Valdés-Mora, WJ Locke, E Bandrés, D Gallego-Ortega, P Cejas, ... Oncotarget 8 (16), 26755, 2017 | 20 | 2017 |
| H2A. Z acetylation and transcription: ready, steady, go! Y Colino-Sanguino, SJ Clark, F Valdes-Mora Epigenomics 8 (5), 583-586, 2016 | 14 | 2016 |
| Single-cell RNAseq uncovers involution mimicry as an aberrant development pathway during breast cancer metastasis F Valdes-Mora, R Salomon, B Gloss, AMK Law, K Murphy, DL Roden, ... bioRxiv, 624890, 2019 | 6 | 2019 |
| PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma RJ Duchatel, ER Jackson, SG Parackal, D Kiltschewskij, IJ Findlay, ... The Journal of Clinical Investigation 134 (6), 2024 | 2 | 2024 |
| ALTEN: A High‐Fidelity Primary Tissue‐Engineering Platform to Assess Cellular Responses Ex Vivo AMK Law, J Chen, Y Colino‐Sanguino, LR Fuente, G Fang, SM Grimes, ... Advanced Science 9 (21), 2103332, 2022 | 2 | 2022 |
| Opera-gsam: Big data processing framework for umi sequencing at high scalability and efficiency PV Caderno, FM Awaysheh, Y Colino-Sanguino, LR De La Fuente, ... 2023 IEEE/ACM 23rd International Symposium on Cluster, Cloud and Internet …, 2023 | 1 | 2023 |
| Performance comparison of high throughput single-cell RNA-Seq platforms in complex tissues Y Colino-Sanguino, LR de la Fuente, B Gloss, AMK Law, K Handler, ... bioRxiv, 2023.04. 04.535585, 2023 | 1 | 2023 |
| EXTH-12. PRECLINICAL AND CASE STUDY EXAMINATION OF THE COMBINATION OF THE CLPP AGONIST ONC201 WITH THE PI3K/AKT INHIBITOR PAXALISIB FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA E Jackson, R Duchatel, M Persson, A Mannan, S Yadavilli, S Parackal, ... Neuro-Oncology 24 (Supplement_7), vii211-vii211, 2022 | | 2022 |
| DIPG-07. Preclinical and case study results underpinning the phase II clinical trial testing the combination of ONC201 and paxalisib for the treatment of patients with diffuse … MD Dun, ER Jackson, RJ Duchatel, ML Persson, A Mannan, S Yadavilli, ... Neuro-Oncology 24 (Supplement_1), i18-i19, 2022 | | 2022 |
| Dissecting the role of histone variant H2A. Z acetylation in transcription regulation Y Colino Sanguino UNSW Sydney, 2019 | | 2019 |
| Clinical relevance of the transcriptional signature regulated by CDC42 in colorectal cancer PC Gallego-Ortega, MA García-Cabezas, Y Colino-Sanguino, J Feliú, ... | | 2017 |
| Acetylated histone variant H2A. Z is involved in the activation of neo-enhancers in prostate cancer L Horvath, J Kench, K Lee, NJ Armstrong, FA Buske, Y Colino-Sanguino, ... Nature Publishing Group, 2017 | | 2017 |
